Cipla Limited and its wholly owned subsidiary Cipla USA Inc. (hereafter referred to as 'Cipla'), announced the launch of Leuprolide Acetate Injection Depot 22.5mg....
The U.S. Food and Drug Administration approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's...
Guerbet (FR0000032526 GBT), a global leader in medical imaging, announced that the U.S. Food and Drug Administration (FDA) after priority review, approved Elucirem (Gadopiclenol),...
Lucid Hearing, LLC, a market leader and global provider of advanced hearing technology and audio solutions, commends the Food and Drug Administration (FDA) for...
Berkshire Biomedical Corporation ("Berkshire" or "the Company"), focused on developing its proprietary, hand-held, automated personalized drug dispensing technology to enhance patient wellness, announced that...
